The world’s largest open scientific conference on HIV and AIDS to be held in Mexico City in July 2019

The International AIDS Society (IAS) has announced that Mexico City, Mexico, will host the 10th IAS Conference on HIV Science (IAS 2019).

IAS 2019 will take place at the Centro Citibanamex on 21-24 July 2019. Held every two years, the IAS Conference on HIV Science is a unique forum for scientists, clinicians, public health experts and community leaders to examine the latest research developments in HIV science and explore how to realistically apply and implement that knowledge to address the epidemic.

IAS 2019 is expected to gather more than 6,000 participants. This is the second time that the IAS has convened a conference in Mexico City; it also hosted the 17th International AIDS Conference (AIDS 2008) there.

“We are excited to bring IAS 2019 to Mexico City,” Anton Pozniak, IAS President-Elect, and IAS 2019 International Chair, said.

“It was at AIDS 2008 in Mexico that the potential impact of ART on reducing HIV transmission was first being talked about and, perhaps more than any previous International AIDS Conference, it brought a renewed focus on the legal and human rights issues faced by vulnerable and most-at-risk populations.”

This will be the third time that the IAS Conference on HIV Science has been held in the Latin America and the Caribbean region. In 2001, Buenos Aires, Argentina, hosted the conference, followed by Rio de Janeiro, Brazil, in 2005.

Dr. Tareq Salahuddin is an award-winning journalist and a Special Correspondent of News Hour. He is a Public Health Professional working in the development sector. Dr. Tareq, a medical graduate, is a member of Public Health Association of Bangladesh and a former member of the Governing Council and Policy Committee of the World Federation of Public Health Associations (WFPHA), a J2J Fellow on HIV/AIDS and a member of the International AIDS Society. To know more about Dr. Tareq, please visit his personal website (www.tareqsalahuddin.net) or simply Google his name.
No Comments